论文部分内容阅读
Introduction Oral fludarabine was introduced in the United States in 2003 for the treatment of patients with hematologic malignancies as an alternative to its intravenous(i.v.) formulation,introduced a decade before.In México,the oral formulation was introduced in 2008 and the i.v.formulation was withdrawn.Accordingly,i.v.